title: Mineralocorticoid receptors: an appealing target to treat coronary microvascular dysfunction in diabetes.
authors.affiliation: Research, Harry S. Truman Memorial Veterans Hospital, Columbia, MO Department of Biomedical Sciences, University of Missouri, Columbia, MO Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO.
authors.forename: Shawn B
authors.initials: SB
authors.lastname: Bender
authors.affiliation: Research, Harry S. Truman Memorial Veterans Hospital, Columbia, MO Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Missouri School of Medicine, Columbia, MO.
authors.forename: Guanghong
authors.initials: G
authors.lastname: Jia
authors.affiliation: Research, Harry S. Truman Memorial Veterans Hospital, Columbia, MO Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Missouri School of Medicine, Columbia, MO Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia, MO sowersj@health.missouri.edu.
authors.forename: James R
authors.initials: JR
authors.lastname: Sowers
mesh_terms: D003326:Coronary Circulation / Q000187:drug effects*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008833:Microcirculation / Q000187:drug effects*; D000451:Mineralocorticoid Receptor Antagonists / Q000008:administration & dosage*; D013148:Spironolactone / Q000008:administration & dosage*
chemical_list: D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone